...
首页> 外文期刊>Journal of Functional Foods >Enhanced bioavailability and relative distribution of free (unconjugated) curcuminoids following the oral administration of a food-grade formulation with fenugreek dietary fibre: A randomised double-blind crossover study
【24h】

Enhanced bioavailability and relative distribution of free (unconjugated) curcuminoids following the oral administration of a food-grade formulation with fenugreek dietary fibre: A randomised double-blind crossover study

机译:口服胡芦巴膳食纤维食品级制剂后,游离(未结合)姜黄素类化合物的生物利用度和相对分布得到增强:一项随机双盲交叉研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Despite the various reports on enhanced bioavailable formulations of curcumin, systemic oral bioavailability of unconjugated curcuminoids remains a challenge. Considering the differences in plasma bioactivity and membrane permeability of free curcuminoids over conjugated metabolites, herein we report a randomised double-blinded crossover study (n = 50) to investigate the relative bioavailability and pharmacokinetics of free curcuminoids following the oral administration of high (1000 mg) and low (250 mg) doses of a food-grade formulation of curcumin with fenugreek dietary fibre as curcumagalactomannosides (CGM), which was reported to exhibit improved blood-brain - barrier permeability in rats. CGM administration provided over 45.5-fold enhancement in free curcuminoids bioavailability with improved pharmacokinetics when compared to unformulated standard curcumin. Further investigations with and without enzymatic hydrolysis of plasma collected over 5 h post administration of CGM at 1000 mg dose revealed higher free curcuminoids in plasma (74 +/- 8%) as compared to conjugated curcuminoids (26 +/- 12%) indicating a significant distribution of free curcuminoids over conjugated curcumin metabolites. (C) 2016 Elsevier Ltd. All rights reserved.
机译:尽管关于姜黄素的生物利用度提高的报道多种多样,但未结合的姜黄素的全身口服生物利用度仍然是一个挑战。考虑到游离姜黄素与共轭代谢物的血浆生物活性和膜通透性的差异,在此我们报告了一项随机双盲交叉研究(n = 50),以研究口服高剂量(1000 mg)后游离姜黄素的相对生物利用度和药代动力学。 )和低剂量(250 mg)的姜黄素食品级配方,其中胡芦巴饮食纤维为姜黄乳糖甘露糖苷(CGM),据报道在大鼠中表现出改善的血脑屏障通透性。与未配制的标准姜黄素相比,CGM给药可提高游离姜黄素生物利用度45.5倍以上,并具有改善的药代动力学。在以1000 mg剂量施用CGM后5小时内收集的血浆是否进行酶水解的进一步研究表明,血浆中的游离姜黄素含量较高(74 +/- 8%),而缀合的姜黄素含量较高(26 +/- 12%),表明游离姜黄素在共轭姜黄素代谢产物上的分布显着。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号